<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Mindbio Therapeutics Corp. — News on 6ix</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp</link>
<description>Latest news and press releases for Mindbio Therapeutics Corp. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 05 May 2026 13:31:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/mindbio-therapeutics-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836838578dffbe2df169510.webp</url>
<title>Mindbio Therapeutics Corp.</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp</link>
</image>
<item>
<title>MindBio Develops Cross-Language AI Speech Analytics Capability for Intoxication Detection Patent applications filed in 15 world firsts using Voice and AI</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp/news/mindbio-develops-cross-language-ai-speech-analytics-capability-for-intoxication-detection-patent-applications-filed-in-15-world-firsts-using-voice-and-ai</link>
<guid isPermaLink="true">https://6ix.com/company/mindbio-therapeutics-corp/news/mindbio-develops-cross-language-ai-speech-analytics-capability-for-intoxication-detection-patent-applications-filed-in-15-world-firsts-using-voice-and-ai</guid>
<pubDate>Tue, 05 May 2026 13:31:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, May 05, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has developed a cross-language speech model for the detection of drug and alcohol intoxication. The language agnostic model is a game changer for the non-invasive detection of a range of neuro</description>
</item>
<item>
<title>MindBio Files Patent Applications in 15 World Firsts</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp/news/mindbio-files-patent-applications-in-15-world-firsts</link>
<guid isPermaLink="true">https://6ix.com/company/mindbio-therapeutics-corp/news/mindbio-files-patent-applications-in-15-world-firsts</guid>
<pubDate>Wed, 29 Apr 2026 11:06:00 GMT</pubDate>
<description>Using Voice and AI to Detect Drug & Alcohol Intoxication15 world first discoveries transform our understanding of physiological reactions to neurologically active substances that when consumed, affect the central nervous system and speech.The prediction model using AI and Voice is a world first and sets a new standard for drug and alcohol detection and testing at scale in regulated environments. VANCOUVER, British Columbia, April 29, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO</description>
</item>
<item>
<title>MindBio Appoints Market Maker Venture Liquidity Providers</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp/news/mindbio-appoints-market-maker-venture-liquidity-providers</link>
<guid isPermaLink="true">https://6ix.com/company/mindbio-therapeutics-corp/news/mindbio-appoints-market-maker-venture-liquidity-providers</guid>
<pubDate>Wed, 15 Apr 2026 01:59:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, April 14, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce subject to regulatory and final approvals, the Company has appointed market making services of Venture Liquidity Providers (VLP) for maintaining an orderly trading market for the common shares of the Co</description>
</item>
<item>
<title>MindBio Appoints National Drug Policy & Mining Industry Expert to Lead South American Mining Industry Commercialisation</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp/news/mindbio-appoints-national-drug-policy-and-mining-industry-expert-to-lead-south-american-mining-industry-commercialisation</link>
<guid isPermaLink="true">https://6ix.com/company/mindbio-therapeutics-corp/news/mindbio-appoints-national-drug-policy-and-mining-industry-expert-to-lead-south-american-mining-industry-commercialisation</guid>
<pubDate>Tue, 24 Feb 2026 14:05:55 GMT</pubDate>
<description>VANCOUVER, BC - February 24, 2026 (NEWMEDIAWIRE) - MindBio Therapeutics Corp. (CSE: MBIO | Frankfurt: WF6 | OTCQB: MBQIF) ("MindBio" or the "Company"), a biotechnology innovator commercializing AI-powered voice analytics for real-time drug and alcoho...</description>
</item>
<item>
<title>MindBio to Revolutionise Drug and Alcohol Testing in the Mining Industry using AI Voice-Based Drug & Alcohol Detection Solution</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp/news/mindbio-revolutionise-drug-alcohol-testing-135943496</link>
<guid isPermaLink="true">https://6ix.com/company/mindbio-therapeutics-corp/news/mindbio-revolutionise-drug-alcohol-testing-135943496</guid>
<pubDate>Mon, 02 Feb 2026 13:59:43 GMT</pubDate>
<description>CEO Meets with Mining and Health Executives in South America to discuss deployment of new drug and alcohol screening solution. Mining deployment of the technology would disrupt drug and alcohol testing in the mining industry and represents a massive...</description>
</item>
<item>
<title>Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp/news/global-oncology-breakthroughs-being-fueled-by-advancements-in-clinical-trials-and-new-therapies-1</link>
<guid isPermaLink="true">https://6ix.com/company/mindbio-therapeutics-corp/news/global-oncology-breakthroughs-being-fueled-by-advancements-in-clinical-trials-and-new-therapies-1</guid>
<pubDate>Tue, 08 Jul 2025 12:50:00 GMT</pubDate>
<description>PALM BEACH, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - ...</description>
</item>
<item>
<title>Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp/news/mustang-bio-granted-orphan-drug-designation-by-us-fda-for-mb-101-il13ra2-targeted-car-t-cells-to-treat-astrocytomas-and-glioblastoma</link>
<guid isPermaLink="true">https://6ix.com/company/mindbio-therapeutics-corp/news/mustang-bio-granted-orphan-drug-designation-by-us-fda-for-mb-101-il13ra2-targeted-car-t-cells-to-treat-astrocytomas-and-glioblastoma</guid>
<pubDate>Mon, 07 Jul 2025 12:30:55 GMT</pubDate>
<description>In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of pa...</description>
</item>
<item>
<title>Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp/news/mustang-bio-regains-compliance-with-nasdaq-capital-market-requirement</link>
<guid isPermaLink="true">https://6ix.com/company/mindbio-therapeutics-corp/news/mustang-bio-regains-compliance-with-nasdaq-capital-market-requirement</guid>
<pubDate>Wed, 05 Mar 2025 21:15:15 GMT</pubDate>
<description>WALTHAM, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (&#x201C;Mustang&#x201D; or ...</description>
</item>
<item>
<title>Mustang Bio Announces Sale of Fixed Assets and Exit of Facility</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp/news/mustang-bio-announces-sale-of-fixed-assets-and-exit-of-facility</link>
<guid isPermaLink="true">https://6ix.com/company/mindbio-therapeutics-corp/news/mustang-bio-announces-sale-of-fixed-assets-and-exit-of-facility</guid>
<pubDate>Thu, 27 Feb 2025 21:05:27 GMT</pubDate>
<description>WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (&#x201C;Mustang&#x201D; or t...</description>
</item>
<item>
<title>Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement</title>
<link>https://6ix.com/company/mindbio-therapeutics-corp/news/mustang-bio-regains-compliance-with-nasdaq-minimum-bid-price-requirement</link>
<guid isPermaLink="true">https://6ix.com/company/mindbio-therapeutics-corp/news/mustang-bio-regains-compliance-with-nasdaq-minimum-bid-price-requirement</guid>
<pubDate>Tue, 11 Feb 2025 21:10:30 GMT</pubDate>
<description>WORCESTER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (&#x201C;Mustang&#x201D; or...</description>
</item>
</channel>
</rss>